HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jing Cui Selected Research

human HRAS protein

1/2020The immunoreactivity of the anti-p21Ras single-chain fragment variant KGH-R1 and its predicted binding sites to p21Ras.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jing Cui Research Topics

Disease

69Neoplasms (Cancer)
12/2022 - 11/2006
67Infections
06/2022 - 04/2005
35Rheumatoid Arthritis
04/2022 - 11/2006
20Trichinellosis
10/2021 - 02/2009
17Inflammation (Inflammations)
02/2022 - 10/2008
11Pancreatic Neoplasms (Pancreatic Cancer)
11/2022 - 11/2010
11Asthma (Bronchial Asthma)
11/2022 - 01/2017
10Hypoxia (Hypoxemia)
11/2021 - 01/2013
10Hypertension (High Blood Pressure)
01/2021 - 06/2003
9Neoplasm Metastasis (Metastasis)
04/2022 - 05/2010
9Sparganosis
05/2017 - 06/2011
8Alzheimer Disease (Alzheimer's Disease)
10/2022 - 03/2005
8Diabetic Retinopathy (Retinopathy, Diabetic)
11/2017 - 01/2007
7Colorectal Neoplasms (Colorectal Cancer)
12/2022 - 12/2008
7Breast Neoplasms (Breast Cancer)
10/2021 - 01/2012
7Carcinogenesis
01/2021 - 11/2006
6Glioblastoma (Glioblastoma Multiforme)
07/2020 - 01/2013
6Obesity
01/2020 - 01/2016
6Hepatocellular Carcinoma (Hepatoma)
01/2020 - 10/2009
6Proliferative Vitreoretinopathy
01/2020 - 03/2009
6Wounds and Injuries (Trauma)
06/2019 - 01/2006
5Prostatic Neoplasms (Prostate Cancer)
12/2022 - 04/2012
5Adenocarcinoma
11/2022 - 11/2006
5Type 2 Diabetes Mellitus (MODY)
12/2021 - 06/2003
5Carcinoma (Carcinomatosis)
09/2020 - 07/2009
5Ovarian Neoplasms (Ovarian Cancer)
09/2019 - 10/2008
5Cysticercosis
07/2013 - 01/2003
4Parkinson Disease (Parkinson's Disease)
08/2022 - 03/2007
4Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 12/2018
4Cognitive Dysfunction
02/2021 - 07/2016
4Epiretinal Membrane (Epiretinal Membranes)
01/2021 - 03/2009
4Edema (Dropsy)
11/2020 - 05/2013
4Pancreatitis
10/2017 - 09/2015
4Colonic Neoplasms (Colon Cancer)
01/2017 - 12/2008
4Paragonimiasis
07/2013 - 01/2003
3Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2022 - 02/2013
3Bites and Stings (Sting)
11/2022 - 01/2021
3Body Weight (Weight, Body)
01/2022 - 01/2018
3Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 10/2021
3Reperfusion Injury
01/2022 - 10/2021
3Potassium Deficiency
06/2021 - 01/2020
3Necrosis
01/2021 - 12/2017

Drug/Important Bio-Agent (IBA)

48Proteins (Proteins, Gene)FDA Link
11/2022 - 01/2003
31AntigensIBA
09/2020 - 01/2003
23VaccinesIBA
02/2022 - 01/2012
23AntibodiesIBA
10/2021 - 04/2005
14Biomarkers (Surrogate Marker)IBA
11/2022 - 01/2011
14Biological ProductsIBA
01/2021 - 12/2008
13Immunoglobulin G (IgG)IBA
05/2022 - 08/2010
11Pharmaceutical PreparationsIBA
01/2022 - 02/2011
9DNA (Deoxyribonucleic Acid)IBA
06/2022 - 11/2006
8AutoantibodiesIBA
01/2021 - 10/2008
7MicroRNAs (MicroRNA)IBA
01/2022 - 07/2014
7Glucose (Dextrose)FDA LinkGeneric
01/2021 - 01/2011
6Retinaldehyde (Retinal)IBA
01/2022 - 01/2007
6AntioxidantsIBA
11/2021 - 11/2016
6Long Noncoding RNAIBA
01/2020 - 08/2017
6brassIBA
11/2019 - 05/2009
6Serine Proteases (Serine Protease)IBA
09/2018 - 01/2014
5Indicators and Reagents (Reagents)IBA
12/2022 - 10/2008
5Anti-Bacterial Agents (Antibiotics)IBA
04/2022 - 05/2017
5Anti-Citrullinated Protein AntibodiesIBA
04/2022 - 05/2009
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
06/2021 - 06/2007
5Peptides (Polypeptides)IBA
01/2021 - 03/2012
5Small Interfering RNA (siRNA)IBA
08/2020 - 01/2011
5Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2019 - 07/2010
4RNA (Ribonucleic Acid)IBA
06/2022 - 01/2018
4DNA VaccinesIBA
02/2022 - 03/2015
4Sirtuin 1IBA
01/2022 - 01/2011
4LB100IBA
09/2021 - 01/2018
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 11/2008
4EnzymesIBA
01/2021 - 03/2009
4Messenger RNA (mRNA)IBA
01/2021 - 03/2015
4LigandsIBA
09/2020 - 03/2009
4Protein Isoforms (Isoforms)IBA
01/2020 - 03/2009
4Triglycerides (Triacylglycerol)IBA
01/2020 - 01/2018
4CholesterolIBA
01/2020 - 01/2018
3NucleotidesIBA
11/2022 - 06/2003
3InterferonsIBA
11/2022 - 01/2021
3Interferon Type IIBA
11/2022 - 01/2021
3Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 12/2019
3Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2022 - 08/2015
3Antiviral Agents (Antivirals)IBA
01/2022 - 01/2013
3InflammasomesIBA
10/2021 - 01/2020
3Therapeutic UsesIBA
10/2021 - 08/2013
3LipidsIBA
07/2021 - 02/2019
3Oxygen (Dioxygen)IBA
03/2021 - 01/2019
3Membrane Proteins (Integral Membrane Proteins)IBA
01/2021 - 12/2013
3Dihydrotachysterol (AT 10)IBA
01/2021 - 02/2013
3SodiumIBA
01/2021 - 05/2014
3Immunoglobulin E (IgE)IBA
11/2020 - 12/2019

Therapy/Procedure

32Therapeutics
11/2022 - 11/2006
6Immunotherapy
10/2021 - 01/2012
6Drug Therapy (Chemotherapy)
09/2021 - 08/2012
6Radiotherapy
07/2020 - 02/2013
4Activities of Daily Living (ADL)
08/2022 - 01/2021
4Lasers (Laser)
11/2017 - 07/2012
4Light Coagulation
11/2017 - 04/2010
4Vitrectomy
04/2016 - 01/2006
3Aftercare (After-Treatment)
05/2022 - 06/2006